Monash Haematology is a dynamic academic research organisation that integrates the best evidence-base into routine patient care.

We provide haematology care to a population of approximately 1.3 million, making it one of the largest services in Australia.

Our mission is to improve the health and well-being of patients with blood disease by providing the best care to every patient through integrated clinical practice, education, and research.

Key leadership areas in clinical care and research include:

  • Lymphoma and Chronic Lymphocytic Leukaemia
  • Acute Leukaemia and Myelodysplastic Syndromes
  • Venous thromboembolic disease
  • Haemoglobinopathy
  • Obstetric Haematology
  • Transfusion medicine

The unit is actively involved in exploring new models of healthcare delivery, the development of personalised diagnostics, and developing the next generation of cellular therapies for malignant blood disease.

We are responsible for training our future workforce through the integration of our clinical services with teaching and academia.

The unit has an international reputation for clinical research and has a large trial portfolio including several first-in-human, investigator-initiated and cooperative trial group studies. Monash Haematology researchers are key players in several national and international clinical registries and are actively involved in service optimisation through clinical audit.

We are active collaborators with several research organisations including School of Clinical Sciences at Monash Health (Monash University), the Australasian Leukaemia and Lymphoma Group, and the Children’s Oncology Group.

Through our partnership with Monash University, we have an emerging basic science and translational research programme embedded within the state-of-the-art Monash Health Translational facility.